Page 8 - Pascal Touchon News Today

Atara Biotherapeutics, Inc. (NASDAQ:ATRA – Get Rating)’s stock price was up 10.4% during mid-day trading on Tuesday . The stock traded as high as $6.49 and last traded at $6.48. Approximately 34,361 shares traded hands during trading, a decline of 97% from the average daily volume of 1,117,919 shares. The stock had previously closed at […]

Equities research analysts forecast that Atara Biotherapeutics, Inc. (NASDAQ:ATRA – Get Rating) will post earnings per share (EPS) of ($0.91) for the current quarter, Zacks Investment Research reports. Three analysts have provided estimates for Atara Biotherapeutics’ earnings, with estimates ranging from ($0.97) to ($0.79). Atara Biotherapeutics also posted earnings per share of ($0.91) in the […]

Equities analysts expect that Atara Biotherapeutics, Inc. (NASDAQ:ATRA – Get Rating) will post sales of $8.84 million for the current fiscal quarter, according to Zacks. Three analysts have made estimates for Atara Biotherapeutics’ earnings. The lowest sales estimate is $5.80 million and the highest is $14.73 million. Atara Biotherapeutics reported sales of $3.87 million in […]

Atara Biotherapeutics, Inc. (NASDAQ:ATRA – Get Rating) has earned an average recommendation of “Hold” from the eight analysts that are currently covering the firm, Marketbeat reports. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating and four have given a buy rating to the company. The […]

A 90,000 ft2 manufacturing facility in Thousand Oaks, CA, is readily expandable with the flexibility to produce both clinical and commercial cell therapies, including allogeneic T-cell and CAR T immunotherapies, according to officials at FUJIFILM Diosynth Biotechnologies, a CDMO. The manufacturing facility complements FUJIFILM’s existing manufacturing operations in College Station, TX, Watertown, MA, and its BioCampus in the UK.

Atara Biotherapeutics, a cell immunotherapy company with two facilities in Thousand Oaks, announced its entrance into a long-term collaboration with Fujifilm Diosynth Biotechnologies, a subsidiary of Fujifilm Corp.

ATRA earnings call for the period ending September 30, 2021.

Atara Biotherapeutics and French pharmaceutical company Pierre Fabre announced a commercialization partnership for Tab-cel, Atara’s off-the-shelf immunotherapy treatment for Epstein-Barr virus. The partnership will cover sales in Europe, the Middle East, Africa, and other emerging markets.

Press release content from Business Wire. The AP news staff was not involved in its creation.

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Aug 9, 2021--